 |
The Medical Device Manufacturers Association (MDMA) is THE VOICE for innovative, entrepreneurial medical technology companies. MDMA’s 2008 Annual Meeting brings leading medical technology executives together with healthcare’s most influential and respected decision-makers. Understanding the impact of industry and government trends has never been more important. Attend. Get informed. Get active.
| » | Agenda | ||
| » | Speaker Biographies | ||
| » | Fees & Registration | ||
| » | Accommodations | ||
| » | Sponsors | ||
| » | Questions / Cancellation Policy |
Companies with annual sales under $500,000 can join the association for free, but must attend the meeting at the non-member rate.
MDMA Programs - 2008 SCHEDULE
|
» Annual Coverage, Reimbursement, and Health Policy Conference » Premarket Approval (PMA) and 510(k) Premarket Notification Seminar |
(last updated 1.24.08)
Click on program titles below for an agenda
| JANUARY | Members-only conference call: 2008 Outlook |
| FEBRUARY | |
| MARCH | |
| APRIL | |
| MAY | |
| JUNE | MDMA Annual Meeting: June 12-13, Washington DC - register now |
| JULY | |
| AUGUST | |
| SEPTEMBER | Premarket Approval (PMA) and 510(k) Premarket Notification Seminar |
| OCTOBER | Commercialization of Medical Devices Seminar |
| NOVEMBER | Coverage, Reimbursement, and Health Policy Conference |
| DECEMBER |
MDMA Annual Meeting
The MDMA Annual Meeting is a premier industry conference which brings executives from innovative medical technology companies together with healthcares most influential and respected decision makers. The program features speakers from industry, Congress, the Food & Drug Administration, and the Centers for Medicare & Medicaid Services. Attendees include high-level medical technology executives, attorneys, consultants, and others seeking to learn more about trends in the industry.
Coverage, Reimbursement, and Health Policy Conference
MDMA’s Annual Coverage, Reimbursement and Health Policy Conference is a must for medical technology companies seeking to better understand and manage issues related to coverage, coding and payment of medical technologies. Designed for the needs of entrepreneurial device companies, the program covers such topics as, evidence standards for coverage determinations in the US and internationally, payment for new technology, and updates in prospective payment systems. This program helps simplify many of the complex challenges facing device companies and provide the necessary insight from top industry and government officials about the latest trends in coverage, reimbursement and health policy issues.
Premarket Approval (PMA) and 510(k) Premarket Notification Seminar
The Premarket Approval (PMA) and 510(k) Premarket Notification Seminar gives attendees a chance to learn the regulations governing 510(k) and PMA premarket submissions from leading FDA attorneys, industry representatives, and FDA officials. The seminar is designed to help companies understand the technical requirements of submissions, provide practical advice on how to prepare them, help manage and maximize communications with FDA, avoid fraud and abuse in clinical trials, and devise a product reimbursement strategy. The program provides valuable insight from a variety of perspectives and gives companies considering submitting a 510(k) or PMA in the future the tools they need to prepare successful submissions.
Commercialization of Medical Devices Seminar
The product commercialization workshop gives participants a chance to interact with leading healthcare executives who shared their real-world experience in successfully bringing medical devices to market. Attendees learn about the importance of developing strong IP, FDA’s pre and post market process, the significance of a successful reimbursement strategy, different options for sales and marketing, and compliance issues.
Compliance Seminar
The MDMA Compliance Seminar provides attendees with an overview of key fraud and abuse issues facing medical technology companies. Government, industry and legal experts discuss recent trends in sales and marketing enforcement activities in the US and abroad. Speakers also address implementing the MDMA Guidelines, the impact of ongoing state and federal litigation, and future trends in compliance activities.
For more information about MDMA programs or membership, please contact Erin Jones at (202) 354-7172.